Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Cannabis Science, Inc (CBIS) 52 Week High Not Far Away!

|Includes: Cannabis Science, Inc. (CBIS)

If you have been following, you are aware that we are focusing a lot of attention in the direction of medical marijuana stocks.

CBIS has shown HUGE growth in these past couple of months and for good reason.

Medical Marijuana has been the topic of a lot of headlines and is going to keep getting legalized in more and more states.

Knowing this we want to take advantage of the stocks at the ground floor in this sector!

Even though CBIS is testing the 52 week high at these levels we still believe there is still HUGE room for growth!

Check out the chart and focus on the past few months.

HUGE amounts of buying is sending this stock to the sky!

We want to emphasize that this sector is going to have more and more attention until the last state has legalized medical marijuana and even then we will see these companies get bigger and bigger!

Today alone we saw a 3,250%+ gain in the amount of CBIS shares traded!

Now do you see why we love this stock so much?

Not to mention CBIS is based out of one of the only places medical marijuana is legal, Colorado!

About CBIS: Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance. The company has a license agreement with Apothecary Genetics Investments LLC. to produce various brand formulations for California medical cannabis market. Cannabis Science, Inc. is based in Colorado Springs, Colorado.

SIGN UP NOW TO OUR FREE NEWSLETTER AND GET FREE REPORTS ON ALL OF OUR STOCK PICKS!

Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance. The company has a license agreement with Apothecary Genetics Investments LLC. to produce various brand formulations for California medical cannabis market. Cannabis Science, Inc. is based in Colorado Springs, Colorado.